I migliori ematologo-oncologi di Ematologia Oncologia - TOP-10 medici

Il Dott. Luis Madero ha oltre 37 anni di esperienza in ematologia oncologica pediatrica, specializzato in disturbi complessi del sangue e trapianti di midollo osseo presso Quironsalud Madrid.

• Responsabile di Emato-Oncologia Pediatrica presso Ospedale Universitario Quironsalud Madrid
• Ha pubblicato 14 libri curati e 75 capitoli di libri su ematologia oncologica
• Membro di SIOP, EBMT e Associazione Spagnola di Ematologia ed Emoterapia
• Esperto nel trattamento di leucemia, linfoma, mieloma multiplo e rari disturbi del sangue

Children's Hematologist. Specialist in bone marrow transplantation

Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Dr. Carmen Martinez Chamorro is an oncohematologist who treats leukemia, lymphoma, and myeloma. She specializes in adult bone marrow transplants.

Education

Carmen Chamorro graduated in Medicine from the University of Valladolid, where she received the National Prize for Research in Surgery.

She trained as a hematologist at the La Princesa University Hospital in Madrid.

Professional experience

From 1997 to 2007 she worked in the Clinical Hematology Department of the Rubera Hospital in Madrid.

He is currently Deputy Head of the Hematology Department at the Quironsalud Madrid Hospital.

Scientific activity

Dr. Carmen Martinez Chamorro is the author of 20 medical articles and a participant in 60 international and national conferences.

Education and Training

Doctor of Medicine, Cum Laude, University of Navarra (1991)

Medical Degree, University of Navarra (1979–1985), Graduated with Honors

Board-Certified Specialist in Medical Oncology, via Spanish MIR system, Clínica Universidad de Navarra (1986–1989)

Advanced Fellowship in Immunotherapy, Cleveland Clinic Foundation, USA

Professional Experience

Head of Medical Oncology (1993–2000) and Director of the Cancer Institute (2000–2002), General Hospital of Catalonia

Director of Hematopoietic Progenitor Transplant Program, General Hospital of Catalonia (1993–2002), accredited by the Catalonian Health Department

Senior Specialist in Oncology, Quirónsalud Torrevieja (since 2002)

Clinical Innovations & Special Programs

Personalized Cancer Therapy using RNA microarrays and pharmacogenomics

Autologous Bone Marrow Transplants and High-Dose Chemotherapy

High-Dose Interleukin-2 Therapy via intravenous bolus for solid tumors

Personalized Cellular Anti-Tumor Vaccines

Hyperthermic Isolated Limb Perfusion with TNF and melphalan

Intra-arterial and Intraoperative Chemotherapy (HIPEC) for advanced cancers

Research & Academic Contributions

Author of 120+ scientific papers and conference presentations

Active contributor to the development of novel cancer immunotherapies and drug personalization strategies

Memberships

AACR – American Association for Cancer Research

ASCO – American Society of Clinical Oncology

ASH – American Society of Hematology

Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.

He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.

He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.

Medical Director of the University of Navarra Clinic

Prof. of hematology and hemotherapy

Dr. Blanca Lopez Ibor is an experienced specialist in children’s hematology and oncology from Spain. She is a lecturer at the Universidad Complutense de Madrid and Universidad CEU San Pablo, and is a consultant for the WHO and UNESCO. Dr Lopez Ibor has over 30 years of experience diagnosing and treating hematological and cancer disorders in children. She is also the head of two foundations that help children with severe health problems.

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.